Business Wire

LevelBlue and Akamai Partner to Launch New Managed Web Application and API Protection Services

12.8.2025 15:00:00 EEST | Business Wire | Press release

Share

LevelBlue, a leading provider of managed security services, strategic consulting, and threat intelligence, today announced the launch of its Managed Web Application and API Protection (WAAP) security service, designed to deliver adaptive, always-on protection that can reduce risk and operational overhead for web application and API security. Powered by Akamai’s industry-leading App & API Protector technology, LevelBlue Managed WAAP combines next-gen web application firewall (WAF), distributed-denial-of service (DDoS) mitigation, bot protection, and foundational API security capabilities paired with LevelBlue’s dedicated WAAP Operations team.

Organizations globally are rapidly scaling their use of applications and APIs to power digital-first strategies. According to Enterprise Strategy Group, the average number of web applications per organization is expected to grow from 145 to more than 200 within two years. Simultaneously, the number of organizations with more than half of their applications using APIs will rise from 32% to 80%. Among the most critical challenges security teams face are:

  • Discovering application and API deployments
  • Scaling adequate protections
  • Swiftly identifying and mitigating attacks
  • Ensuring security does not impact performance

In addition, many struggle with staff constraints and an expertise gap. As environments grow more complex, half of midmarket organizations say it's harder to secure web apps and APIs than it was just two years ago, and so many are seeking external help and simplified, consolidated solutions. LevelBlue Managed WAAP directly addresses these needs, delivering measurable security outcomes while streamlining operations.

“Today, a surprising number of organizations rely on multiple tools that are not purpose-built for web application and API security—leading to complexity, silos, and rising costs,” said Sundhar Annamalai, president of LevelBlue. “LevelBlue offers an alternative: proven services that consolidate and simplify protections with predictable investment. By combining LevelBlue’s operational expertise with Akamai’s proven technology, organizations can stay ahead of evolving threats and create cyber resilience for critical digital capabilities.”

LevelBlue Managed WAAP is available in two tiers, Essential and Advanced, giving organizations the flexibility to choose a service level that best meets their needs. Core benefits include:

  • Access 24/7 WAAP expertise: Gain a fully operational team of specialists delivering around-the-clock support, monitoring, and advisory to improve WAAP protection.
  • Discover and secure critical assets: Automatically identify and classify web apps and APIs—prioritize those exposed or handling sensitive data, and scale protection as needed.
  • AI-Powered Threat Defense: Combine AI-driven detection with global threat intelligence to spot anomalies, adapt to new attack vectors, and stay ahead of threats.
  • Streamlined Security Management: Eliminate manual tuning with expert-led, automated policy management, boosting efficiency, reducing false positives, and aligning with modern DevOps workflows.

“In 2024 alone, Akamai saw over 311 billion web app attacks. As AI accelerates, threats are harder to spot, and security is tougher to control,” said Rupesh Chokshi, Senior Vice President and General Manager of Akamai’s Application Security Portfolio. “Akamai and LevelBlue’s partnership gives customers access to a trusted, reliable team that combines industry-leading technology with the deep operational expertise of one of the world’s largest MSSPs. It’s a powerful combination with a flexible solution that can fast-track organizations to resilient protection and compliance."

To learn more about LevelBlue Managed WAAP services, please visit here.

About LevelBlue
We simplify cybersecurity through award-winning managed services, experienced strategic consulting, threat intelligence, and renowned research. Our team is a seamless extension of yours, providing transparency and visibility into security posture and continuously working to strengthen it.

We harness security data from numerous sources and enrich it with artificial intelligence to deliver real-time threat intelligence- this enables more accurate and precise decision making. With a large, always-on global presence, LevelBlue sets the standard for cybersecurity today and tomorrow. We easily and effectively manage risk, so you can focus on your business.

Welcome to LevelBlue. Cybersecurity. Simplified. Learn more at www.levelblue.com.

About Akamai
Akamai is the cybersecurity and cloud computing company that powers and protects business online. Our market-leading security solutions, superior threat intelligence, and global operations team provide defense in depth to safeguard enterprise data and applications everywhere. Akamai’s full-stack cloud computing solutions deliver performance and affordability on the world’s most distributed platform. Global enterprises trust Akamai to provide the industry-leading reliability, scale, and expertise they need to grow their business with confidence. Learn more at akamai.com and akamai.com/blog, or follow Akamai Technologies on X and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250812788980/en/

Contacts

Media Contact
Jessica Bettencourt
Inkhouse for LevelBlue
levelblue@inkhouse.com
(774) 451-5142

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Mosaic Therapeutics appoints Dr Vince O'Neill, MD, as Head of R&D1.4.2026 12:11:00 EEST | Press release

Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) a clinical-stage oncology therapeutics company developing next-generation, Synergistic Precision combination therapies, today announced the appointment of Dr Vince O’Neill as Head of Research and Development (R&D) to support its next phase of growth. “We are delighted to welcome Vince to the Mosaic leadership team at this pivotal stage of the company’s evolution,”said Thomas Fuchs, CEO, Mosaic Therapeutics.“His deep expertise in targeted oncology drug development and diagnostics will be instrumental as we advance our pipeline to bring transformative therapies to patients in need.” Vince is a board-certified medical oncologist and highly experienced biotechnology executive, bringing over two decades of therapeutic and diagnostic R&D experience within industry to Mosaic Therapeutics, with a track record spanning from IND through to NDA/BLA/MAA approval. Most recently he served at BioXcel Therapeutics as EVP, Head of Product Developme

The AI Summit London Launches Strategic Partnerships with London Business School and General Purpose to Ignite New Era in AI Leadership1.4.2026 10:00:00 EEST | Press release

The AI Summit London, the conference where commercial AI comes to life, has announced strategic collaborations with London Business School and General Purpose to introduce two dedicated AI Training programmes, taking place ahead of the conference on 9 June. Drawing upon the globally recognised expertise in executive education at the London Business School’s Data Science & AI Initiative (DSAI), the one-day AI Leadership Accelerator is a high-impact session designed to equip senior business leaders with the knowledge and tools to unlock real and profitable value from AI. The DSAI at London Business School helps leaders make sense of AI in a way that goes beyond the hype, focusing on what it really means for their organisations, industries, and competitive positioning. Drawing on rigorous, cross-disciplinary research, DSAI provides clear, evidence-based insights - equipping executives with the perspective needed to make confident, high-stakes decisions. “Through our work we increasingly s

Samsung Research Reveals Over Half of Europeans Admit to Looking at a Stranger's Phone Screen in Public – With Nearly a Quarter Doing so out of Sheer Curiosity1.4.2026 09:00:00 EEST | Press release

As millions of Europeans2 get ready to enjoy the Easter weekend, new research from Samsung finds Europe’s public spaces have become shared screens: 56% of people say they have accidentally looked at a stranger’s phone, citing public transport as the most likely place to notice someone else’s screen (57%). Nearly one in four Europeans2 (24%) admit to looking at someone else’s phone out of curiosity, exposing a stream of private content from personal photos to bank details. Samsung Electronics surveyed 11,000 Europeans2 to support the launch of the Galaxy S26 Ultra, which introduces a built-in Privacy Display. This new hardware-based technology keeps screen content visible only from the front to protect privacy from side angles, without compromising the viewing experience3. The study further reveals a gap between perceived phone privacy and reality: While 48%* feel their own phone use is private when using it in crowded places, 52%** find it easy to view someone else’s screen in public.

RevolKa Reimagines Antibody Engineering with "RevoAb ® "1.4.2026 07:30:00 EEST | Press release

RevolKa Ltd. (RevolKa), a venture-backed biotech company providing an advanced AI protein engineering technology platform, called aiProtein®, is pleased to announce the official global launch of RevoAb®, an innovative and quick online service for antibody sequence optimization to solve challenges in physicochemical properties, especially antibodyyields. RevoAb®:The Next-Gen AI Antibody Design Since December 2023, RevolKa has provided an antibody optimization services utilizing aiProtein®. The newly launched RevoAb® is a quick intuitive online antibody sequence optimization service that integrates RevolKa’s core technology—the "Refined Naturalness Framework Engineering". RevoAb® is designed to generate antibody framework sequences optimized for improved physicochemical properties, especially protein expression levels, without trade-off of affinity. This allows researchers worldwide to experience RevolKa’s high-performance antibody design. Key Advantages of RevoAb® Speed: Multiple optimi

Global Beauty Market Grows 10% as AI and E-commerce Reshape Consumer Buying1.4.2026 04:00:00 EEST | Press release

NielsenIQ (NYSE:NIQ), a global leader in consumer intelligence, today released its State of Beauty 2026 report, showing the global beauty market grew 10% year-on-year, with E-commerce expanding six times faster than in-store sales. The findings highlight a rapid shift to digital-first, AI-influenced commerce across key global markets. As consumer expectations evolve toward convenience, personalization, and seamless digital experiences, beauty brands are under increasing pressure to adapt. From AI-powered product discovery to social commerce and livestream shopping, the path to purchase is becoming more dynamic—requiring brands to move faster and engage consumers across an increasingly complex ecosystem. Key findings from the State of Beauty 2026 report: Global beauty sales grew 10% year-over-year, driven by strong digital acceleration E-commerce is growing 6x faster than in-store sales, reshaping channel strategies 49% of consumers are willing to pay more for locally made products, ref

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye